Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Products/Services
The Accountant Shortage Is Showing Up in Financial Statements
Advance Auto Parts and others have cited a lack of skilled accounting personnel for material weaknesses in their financial-reporting controls, a key predictor of restatements.
FDA Approval Isn't Always a Happy Day for Biotech Investors
In recent weeks, three closely watched FDA decisions came in positive for the companies—followed by their stocks going negative. Source link
Electric-Vehicle Startup Fisker Is Reborn Into a Crowded, Competitive Field
California-based Fisker is finally putting its first cars into the hands of U.S. customers, 2½ years after going public amid a frenzy on Wall Street
America Is Wrapped in Miles of Toxic Lead Cables
Listen to article (3 minutes) AT&T, Verizon and other telecom giants have left behind a sprawling network of cables covered in toxic lead that stretches
Obesity Drugs Won't Starve These Other Potential Blockbusters
Stocks of developers of fatty liver disease treatments had been on a tear until results from Eli Lilly’s medication were published last week. Source link
Goodbye, Volkswagen: China's New EV Winners
The new top dogs in China’s electric vehicle market are starting to thin out the pack. Tesla is in the running, but most other foreign
Iran Floods Global Markets With Cheap Oil as Saudi Arabia Cuts Output
Iranian crude exports have hit a five-year high in recent months as the country ships more oil to China and other buyers. Source link
Meta's Threads App Sees Early Success, Drawing Advertiser Interest and Twitter's Ire
In less than 24 hours, the app has signed up more than 30 million users, surged to the top of download charts and become a
Complex Fund Names May Be a Warning Sign for Investors
The more-wordy your fund name, the worse it does, says a professor who ran the numbers. But the reason isn’t clear. Source link
FDA Approves Leqembi, Extending Alzheimer's Treatment to More Patients
Medicare enrollees can get the anti-amyloid treatment as a result of the agency’s full approval. Source link